A randomised open-label phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC â the ETOP and EORTC SPLENDOUR trial
Peters, Solange, Danson, Sarah, Hasan, Baktiar, Dafni, Urania, Reinmuth, Niels, Majem, Margarita, Tournoy, Kurt G., Mark, Michael T., Pless, Miklos, Cobo, Manuel, Rodriguez-Abreu, Delvys, Falchero, LiJournal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2020.06.011
Date:
June, 2020
File:
PDF, 5.21 MB
2020
File converter
More search results
More benefits 
